Clinical Trials for TNBC, Triple Negative Breast Cancer

Find clinical trials for tnbc, triple negative breast cancer. Discover research opportunities and treatment options in your area.

6 Active Trials Found

Showing 6 trials on this page

Page 1 of 1

Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer

NCT ID: NCT06977542

This clinical trial is studying a new treatment approach for women with early or locally advanced triple-negative breast cancer (TNBC). The goal is to see if combining a medication called ivonescim...

Not yet recruiting

Phase: PHASE2 Type: interventional

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT ID: NCT06305962

This clinical trial is studying a new treatment called 177Lu-anti-PD-L1 for patients with advanced non-small cell lung cancer (NSCLC) that has spread and is no longer responding to standard treatme...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Wollongong, New South Wales, Australia, Woolloongabba, Queensland, Australia +6 more

QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC

NCT ID: NCT06786026

This clinical trial is studying a new treatment approach for women with triple-negative breast cancer (TNBC) that has spread or returned after initial treatment. The researchers want to see how eff...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)

NCT ID: NCT06682195

The NEOTORCH-BREAST02 clinical trial is studying a new treatment approach for women with triple negative breast cancer (TNBC). This trial combines a type of immunotherapy called Toripalimab with st...

Recruiting

Phase: PHASE2 Type: interventional Locations: Hangzhou, , China, Shanghai, , China +11 more

Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

NCT ID: NCT06220214

This clinical trial is looking at new ways to monitor how well chemotherapy is working for women with early stage breast cancer. Specifically, the study is comparing a special type of mammogram tha...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Stony Brook, New York, United States

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

NCT ID: NCT06404736

This clinical trial, titled "QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer," is investigating a new treatment approach for women with early-stage triple-nega...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Not Us/Canada, China, Shanghai, , China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions